Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Min Hwan Kim

Showing results (61-70 of 119) with videos related to

Pageof 12
Sort By:
International Journal of Biological Macromolecules|September 18, 2020
Monopotassium phosphate-reinforced in situ forming injectable hyaluronic acid hydrogels for subcutaneous injectionJi-Hye Seo, Song Yi Lee, Sungyun Kim, et al.
Drug Delivery|August 29, 2017
Novel reverse electrodialysis-driven iontophoretic system for topical and transdermal delivery of poorly permeable therapeutic agentsKi-Taek Kim, Joon Lee, Min-Hwan Kim, et al.
Plos One|March 25, 2015
Anaplastic lymphoma kinase gene copy number gain in inflammatory breast cancer (IBC): prevalence, clinicopathologic features and prognostic implicationMin Hwan Kim, Soohyeon Lee, Ja Seung Koo, et al.
Biomaterials|February 9, 2019
Macrophage cell tracking PET imaging using mesoporous silica nanoparticles via in vivo bioorthogonal F-18 labelingHyeon Jin Jeong, Ran Ji Yoo, Jin Kwan Kim, et al.
JCO Precision Oncology|October 2, 2025
Artificial Intelligence-Powered Human Epidermal Growth Factor Receptor 2 Quantification and Clinical Outcomes in Human Epidermal Growth Factor Receptor 2-Positive Biliary Tract Cancer Treated With Trastuzumab Plus Folinic Acid, Fluorouracil, and OxaliplatinHongsik Kim, Chiyoon Oum, Soo Ick Cho, et al.
Frontiers in Oncology|June 21, 2021
Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast CancerSoong June Bae, Jee Hung Kim, Sung Gwe Ahn, et al.
Pharmaceutics|August 29, 2024
Nanocrystal Formulation to Enhance Oral Absorption of Silybin: Preparation, In Vitro Evaluations, and Pharmacokinetic Evaluations in Rats and Healthy Human SubjectsSeungRee Seo, Gwan-Young Kim, Min-Hwan Kim, et al.
Archives of Pharmacal Research|July 31, 2017
Determination and validation of LJ-2698, a potent human A<sub>3</sub> adenosine receptor antagonist, in rat plasma by liquid chromatography-tandem mass spectrometry and its application in pharmacokinetic studyJae-Young Lee, Ju-Hwan Park, Ki-Taek Kim, et al.
The Prostate|September 22, 2020
<sup>18</sup> F-labeled 1,2,3-triazole-linked Glu-urea-Lys-based PSMA ligands have good pharmacokinetic properties for positron emission tomography imaging of prostate cancerByoung Se Lee, So Young Chu, Woon Jung Jung, et al.
Nuclear Medicine and Biology|May 22, 2018
Feasibility of myocardial PET imaging using a benzylguanidine analog: meta-(3-[<sup>18</sup>F]fluoropropyl)benzylguanidine ([<sup>18</sup>F]mFPBG)Sang-Keun Woo, Byung Seok Moon, Bom Sahn Kim, et al.
Pageof 12

Showing results (61-70 of 119) with videos related to

Sort By:
Pageof 12
International Journal of Biological Macromolecules|September 18, 2020
Monopotassium phosphate-reinforced in situ forming injectable hyaluronic acid hydrogels for subcutaneous injectionJi-Hye Seo, Song Yi Lee, Sungyun Kim, et al.
Drug Delivery|August 29, 2017
Novel reverse electrodialysis-driven iontophoretic system for topical and transdermal delivery of poorly permeable therapeutic agentsKi-Taek Kim, Joon Lee, Min-Hwan Kim, et al.
Plos One|March 25, 2015
Anaplastic lymphoma kinase gene copy number gain in inflammatory breast cancer (IBC): prevalence, clinicopathologic features and prognostic implicationMin Hwan Kim, Soohyeon Lee, Ja Seung Koo, et al.
Biomaterials|February 9, 2019
Macrophage cell tracking PET imaging using mesoporous silica nanoparticles via in vivo bioorthogonal F-18 labelingHyeon Jin Jeong, Ran Ji Yoo, Jin Kwan Kim, et al.
JCO Precision Oncology|October 2, 2025
Artificial Intelligence-Powered Human Epidermal Growth Factor Receptor 2 Quantification and Clinical Outcomes in Human Epidermal Growth Factor Receptor 2-Positive Biliary Tract Cancer Treated With Trastuzumab Plus Folinic Acid, Fluorouracil, and OxaliplatinHongsik Kim, Chiyoon Oum, Soo Ick Cho, et al.
Frontiers in Oncology|June 21, 2021
Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast CancerSoong June Bae, Jee Hung Kim, Sung Gwe Ahn, et al.
Pharmaceutics|August 29, 2024
Nanocrystal Formulation to Enhance Oral Absorption of Silybin: Preparation, In Vitro Evaluations, and Pharmacokinetic Evaluations in Rats and Healthy Human SubjectsSeungRee Seo, Gwan-Young Kim, Min-Hwan Kim, et al.
Archives of Pharmacal Research|July 31, 2017
Determination and validation of LJ-2698, a potent human A<sub>3</sub> adenosine receptor antagonist, in rat plasma by liquid chromatography-tandem mass spectrometry and its application in pharmacokinetic studyJae-Young Lee, Ju-Hwan Park, Ki-Taek Kim, et al.
The Prostate|September 22, 2020
<sup>18</sup> F-labeled 1,2,3-triazole-linked Glu-urea-Lys-based PSMA ligands have good pharmacokinetic properties for positron emission tomography imaging of prostate cancerByoung Se Lee, So Young Chu, Woon Jung Jung, et al.
Nuclear Medicine and Biology|May 22, 2018
Feasibility of myocardial PET imaging using a benzylguanidine analog: meta-(3-[<sup>18</sup>F]fluoropropyl)benzylguanidine ([<sup>18</sup>F]mFPBG)Sang-Keun Woo, Byung Seok Moon, Bom Sahn Kim, et al.
Pageof 12